Systemic TNF administration in psoriatic patients: a promising therapeutic modality for severe psoriasis
- 1 February 1991
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 124 (2) , 209-210
- https://doi.org/10.1111/j.1365-2133.1991.tb00439.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.Proceedings of the National Academy of Sciences, 1990
- Absence of tumor necrosis factor-? in suction blister fluids and stratum corneum from patients with psoriasisArchives of Dermatological Research, 1989
- Tumour necrosis factor-α in murine autoimmune 'lupus' nephritisNature, 1988
- Phase I study of recombinant human tumor necrosis factorCancer Chemotherapy and Pharmacology, 1987
- Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesImmunology Today, 1986
- Interleukin-1-Like Activity in Horny Layer Extracts: Decreased Activity in Scale Extracts of Psoriasis and Sterile Pustular DermatosesDermatology, 1986
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975